Insider filing · ELVN
Samuel Kintz
PRESIDENT AND CEO
profile →
Enliven Therapeutics, Inc.
ELVN · Healthcare · 61 filings in 24 months
ticker →
Samuel Kintz sold $260K of Enliven Therapeutics (ELVN)
Executed Mar 17 2025, disclosed Mar 19 2025, 2 days later.
Value, as filed
$260K
12,500 sh × $20.83
Executed
Mar 17 2025
the trade date, as filed
Disclosed
Mar 19 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SKSamuel Kintz (PRESIDENT AND CEO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $273K of ELVN (12,500 sh × $21.82, as filed), executed Nov 17 2025.
The name
ELVNHealthcare · Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibito…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Samuel Kintz in ELVN
ELVNSALE
Enliven Therapeutics, Inc.
$273K12,500 sh × $21.82
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. $267K
12,500 sh × $21.33
Exec Oct 17 2025
Filed Oct 21 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. $208K
10,393 sh × $20.02
Exec Aug 18 2025
Filed Aug 20 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. $106K
4,687 sh × $22.69
Exec Jul 17 2025
Filed Jul 21 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. $232K
10,502 sh × $22.08
Exec Jun 17 2025
Filed Jun 18 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. $150K
7,500 sh × $20.05
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. $107K
5,330 sh × $20.08
Exec May 1 2025
Filed May 5 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. $758K
27,047 sh across 2 lots
Exec Oct 8 2024
Filed Oct 10 2024 · 5:30 PM ET